openPR Logo
Press release

Why the Parkinson’s Disease Drugs Market is set to explode? Top Companies : Pfizer, Roche, Merck, Novartis, Orion Pharma, UCB, Teva Pharmaceutical, Vertical Pharmaceuticals, ACADIA Pharmaceuticals Inc., Impax Laboratories, Lundbeck

07-10-2019 12:33 PM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd

Why the Parkinson’s Disease Drugs Market is set to explode? Top

The Global Parkinson’s Disease Drugs Market is likely to grow in the coming years due to recent advances in molecular data that has contributed to genome sequencing. According to a report published by Fortune Business Insights, titled “Parkinson’s Disease Drugs Market: Global Market Analysis, Insights, and Forecast, 2018 to 2026,” the market will be valued at US$ 8,383.2 Mn by the end of 2026

Browse Complete Report Details:
https://www.fortunebusinessinsights.com/industry-reports/parkinson-s-disease-drugs-market-100655

Fortune Business Insights states that the market was valued at US$ 4,500.0 Mn in 2018 and is likely to exhibit a CAGR of8.1 in the forecast period.

Top Players Overview:

Some of the leading companies that are operating in the global Parkinson’s Disease Drugs Market are

• Pfizer
• Roche
• Merck
• Novartis
• Orion Pharma
• UCB
• Teva Pharmaceutical
• Vertical Pharmaceuticals
• ACADIA Pharmaceuticals Inc.
• Impax Laboratories
• Lundbeck

Recent discoveries in pharmaceuticals and drug delivery methods have boosted the global Parkinson’s Disease Drugs Market. Increasing FDA approvals for drug used for manufacturing pharmaceuticals are likely to favor the growth of the global Parkinson’s Disease Drugs Market. Besides this, advancements in drug delivery system have led to an increase in demand for related pharmaceuticals.

Major Segmentation:

Furthermore, increasing focus on research and development of newer pharmaceuticals by leading healthcare companies is likely to boost the market in the forthcoming years. Fortune Business Insights has stated that Parkinson’s Disease Drugs Market in North America will emerge in the forecast period.

Request Sample PDF:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/parkinson-s-disease-drugs-market-100655

Regional Analysis:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Parkinson’s Disease Drugs Market is likely to expand with the highest CAGR, due to an increasing patient pool and favorable reimbursement policies in this region, in the forecast period.

The report provides detailed market analysis and exclusive insights for the global Parkinson’s Disease Drugs Market. Fortune Business Insights segments the market based on various factors in this report. Besides this, Fortune Business Insights has labeled out leading market players.

Major Table of Content For Parkinson’s Disease Drugs Market:

1. Introduction
2. Executive Summary
3. Market Dynamics
4. Key Insights
5. Global Parkinson’s Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
6. North America Parkinson’s Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
7. Europe Parkinson’s Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
8. Asia Pacific Parkinson’s Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
9. Middle East and Africa Parkinson’s Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
10. Latin America Parkinson’s Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
11. Competitive Landscape
12. Company Profile
13. Conclusion

Speak to Analyst:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/parkinson-s-disease-drugs-market-100655

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Why the Parkinson’s Disease Drugs Market is set to explode? Top Companies : Pfizer, Roche, Merck, Novartis, Orion Pharma, UCB, Teva Pharmaceutical, Vertical Pharmaceuticals, ACADIA Pharmaceuticals Inc., Impax Laboratories, Lundbeck here

News-ID: 1800715 • Views: 177

More Releases from Fortune Business Insights Pvt. Ltd

Influenza Medication Market - How COVID19 impacting the healthcare industry? Key …
Influenza Medication Market Size, Share & Industry Analysis, By Treatment (Baloxavir marboxil, Oseltamivir phosphate, Others), By Influenza Type (Influenza A, Influenza B), By Route of Administration (Oral, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026. Get Sample Report To Know The Impact of Covid19 on this Industry at: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/influenza-medication-market-101843 Top Key Players: Alvogen, Amneal Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Seqirus (CSL), Genentech,
Adult Diapers Market - How COVID19 impacting the healthcare industry? Key Player …
Adult Diapers Market Size, Share & Industry Analysis, By Product Type (Underwear & Briefs, Pads & Guards, and Drip Collectors & Bed Protectors), By Gender (Male and Female) By Distribution Channel (Institutional Sales, Retail Stores, and Online Channels) and Regional Forecast, 2019-2026. Get Sample Report To Know The Impact of Covid19 on this Industry at: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/adult-diapers-market-102077 Top Key Players: PAUL HARTMANN AG, TZMO SA, Essity, Wellspect HealthCare (Dentsply Sirona), Ontex, Kimberly-Clark Corporation,
What's driving the U.S. Biosimilars Market Growth? Prominent Players: F. Hoffman …
The "U.S. Biosimilars Market 2020" will gain momentum from the increasing government support to adopt biosimilars in the healthcare sectors. According to a report by Fortune Business Insights, titled, "Biosimilars: U.S. Market Analysis, Insights and Forecast, 2019-2026," The U.S. Biosimilars Market is projected to reach US$ 17,696.0 Mn by 2026. The report provides valuable insights into the drivers influencing growth of the market. As per the report, The U.S. Biosimilars
Sports Medicine Market - How COVID19 impacting the healthcare industry? Key Play …
Sports Medicine Market Size, Share & Industry Analysis, By Device Type (Surgery Devices, Bone Reconstruction Devices, Body Support Devices, Others), By Application (Knee, Head & Neck, Shoulder, Ankle & Foot, Wrist & Elbow, Others) By End User (Hospitals, Specialty Clinics), and Regional Forecast, 2019-2026. Get Sample Report To Know The Impact of Covid19 on this Industry at: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/sports-medicine-market-102034 Top Key Players: Arthrex, Inc., Smith & Nephew, Stryker, CONMED Corporation, Zimmer Biomet, Johnson

All 5 Releases


More Releases for Parkinson’s

Parkinson’s Disease Therapeutic Market- Trends, Outlook 2025
Parkinson’s disease (PD) is a chronic disorder characterized by the malfunctioning and death of vital nerve cells in the brain, and can be characterized by tremor, dementia, and depression. Parkinson’s disease progression leads to uncontrolled body movement of the patient. There is no cure presently for parkinson’s disease only treatments options such as medication and surgery to manage the symptoms are available. Parkinson’s disease mainly affects people over 50 and
Parkinson’s disease Therapeutics Parkinson’s disease Therapeutics Market to …
This report studies the global Parkinson's Disease Therapeutics market, analyzes and researches the Parkinson's Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie ….. Ask for sample copy @ https://www.researchtrades.com/request-sample/1199125 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Parkinson's Disease Therapeutics can be split into Medications Therapeutics Medical Devices Therapeutics Buy
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent. Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial